Stephens Downgrades Centessa Pharmaceuticals (CNTA) to Equal Weight
Tweet
Share
E-mail
Get Alerts CNTA Hot Sheet
Price: $40.50 --0%
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Stephens analyst Sudan Loganathan downgraded Centessa Pharmaceuticals (NASDAQ: CNTA) from Overweight to Equal Weight.
For an analyst ratings summary and ratings history on Centessa Pharmaceuticals click here. For more ratings news on Centessa Pharmaceuticals click here.
Shares of Centessa Pharmaceuticals closed at $27.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Boeing names Ryan Shedd as new SVP and controller
- BofA says CTA Treasury shorts stable, euro short-cover risk rises
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
